A barrier-crossing and immune checkpoint-blocking antibody fusion protein for enhanced glioma-targeted immunotherapy.
- DOI
- 10.1016/j.ajps.2026.101175
- Published
- 2026 Aug
- Container
- Asian journal of pharmaceutical sciences
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ajps.2026.101175,
title = {A barrier-crossing and immune checkpoint-blocking antibody fusion protein for enhanced glioma-targeted immunotherapy.},
author = {Bao Y and Yang S and Ding Y and Zhou J and Zheng X and Chen R and Jiang Z and Meng N and Pan D and Lu J and Guan J and Ye J and Zhu H and Xu N and Xie C and Yu L and Lu L and Lu W},
year = {2026},
journal = {Asian journal of pharmaceutical sciences},
doi = {10.1016/j.ajps.2026.101175},
url = {https://doi.org/10.1016/j.ajps.2026.101175}
}RIS
TY - JOUR TI - A barrier-crossing and immune checkpoint-blocking antibody fusion protein for enhanced glioma-targeted immunotherapy. AU - Bao Y AU - Yang S AU - Ding Y AU - Zhou J AU - Zheng X AU - Chen R AU - Jiang Z AU - Meng N AU - Pan D AU - Lu J AU - Guan J AU - Ye J AU - Zhu H AU - Xu N AU - Xie C AU - Yu L AU - Lu L AU - Lu W PY - 2026 JO - Asian journal of pharmaceutical sciences DO - 10.1016/j.ajps.2026.101175 UR - https://doi.org/10.1016/j.ajps.2026.101175 ER -
APA
Y, B., S, Y., Y, D., J, Z., X, Z., R, C., Z, J., N, M., D, P., J, L., J, G., J, Y., H, Z., N, X., C, X., L, Y., L, L., & W, L. (2026). A barrier-crossing and immune checkpoint-blocking antibody fusion protein for enhanced glioma-targeted immunotherapy.. Asian journal of pharmaceutical sciences. https://doi.org/10.1016/j.ajps.2026.101175
Source records
- pubmed · retrieved 2026-09-27T01:31:29.117Z